Research Management and Impact Tool (ReMIT)
About
Sign-in / Sign-up
Open menu
Birgit Schramm
Epicentre
Studies
Status: Completion
Enhanced monitoring of tenofovir-lamivudine-dolutegravir (TLD) replacing first-line HIV-antiretroviral treatment in Chiradzulu District, Malawi (EMEDT)
Study details:
Observational study
in
Malawi
Principal investigator:
Birgit Schramm
Latest update:
Document added | 23rd September 2024
Modal title
About
Sign-in / Sign-up
Admin panel
MSF science portal
About this site
